CARL · Carlsmed, Inc.

$12.78 +0.47 (+3.82%) At close · Jul 29

Market Cap

$334.65M

27.18M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mike Cordonnier	CEO	$480,822	—	$353,218	$1,510,370	$414,709	$30,848	$2,789,967
Scott Durall	—	$411,260	—	—	$802,741	$283,770	$18,501	$1,516,272

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Mike Cordonnier	CEO	$362,583	—	—	—	$144,770	$13,340	$520,693
Chief Commercial	Officer	$116,311	—	—	$250,218	$50,558	—	$417,087

Key facts CIK 1794546 CUSIP 14280C105 13F (30d) 11 filings 11 filers Visit website Investor relations